Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: A population based cohort study

被引:56
作者
Wu, JH
Haan, MN [1 ]
Liang, J
Ghosh, D
Gonzalez, HM
Herman, WH
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth Hlth Management & Policy, Ann Arbor, MI 48109 USA
关键词
diabetes mellitus; Mexican Americans; antidiabetic drugs; physical and cognitive functioning;
D O I
10.1016/S1047-2797(02)00464-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE: The current study was designed to evaluate the utility of antidiabetic medications in affecting changes in physical and cognitive functioning among older Mexican Americans with diabetes over a 2-year period. METHODS: A longitudinal analysis with repeated measurements between 1999 and 2001 was performed in a cohort of Mexican Americans, 60 or older, in the SALSA Project. Statistical analysis was conducted using a generalized estimating equation. RESULTS: For subjects with diagnosed diabetes less than or equal to 5 years (N = 381), there was less decline in physical and cognitive functioning over 2 years among subjects on treatment, compared to those without treatment. For subjects with diagnosed diabetes of 5+ years (N = 337), the effect of antidiabetic medications was more significant in preventing the decline in physical and cognitive functioning (ADL: mean in log scale = -0.10, 95% CI = -0.16, -0.04, 3MS: mean = 6.35, 95% CI = 3.23, 9.48). Combination therapy of antidiabetic agents appeared to be more effective than monotherapy in preventing the decline in physical and cognitive functioning for subjects. CONCLUSIONS: Antidiabetic drugs appear to be useful in alleviating the decline in physical and cognitive functioning among older Mexican Americans with diabetes, especially for those with a longer duration of the disease. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 57 条
[1]  
[Anonymous], 1983, DISABILITY DISADVANT
[2]   The disablement process: A conceptual framework for dementia-associated disability [J].
Barberger-Gateau, P ;
Fabrigoule, C ;
Amieva, H ;
Helmer, C ;
Dartigues, JF .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 13 (02) :60-66
[3]  
Bastida E, 2001, J Community Health Nurs, V18, P75, DOI 10.1207/153276501300118494
[4]   The prevalence and health burden of self-reported diabetes in older Mexican Americans: Findings from the Hispanic established populations for epidemiologic studies of the elderly [J].
Black, SA ;
Ray, LA ;
Markides, KS .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (04) :546-552
[6]  
Blonde L, 2000, Manag Care, V9, P11
[7]   Non-insulin-dependent diabetes mellitus in minorities in the United States [J].
Carter, JS ;
Pugh, JA ;
Monterrosa, A .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) :221-232
[8]   Troglitazone: An antidiabetic agent (Reprinted) [J].
Chen, C .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (09) :905-925
[9]   An overview of metformin in the treatment of type 2 diabetes mellitus [J].
Davidson, MB ;
Peters, AL .
AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) :99-110
[10]  
de Lissovoy G, 2000, AM J MANAG CARE, V6, P573